值得注意的是，在国内市场产品结构升级的同时，通化东宝也在谋求海外市场更大的发展与出口产品的 结构升级。尽管通化东宝已拥有二十多年的出口经验，但出口产品基本以胰岛素原料药为主，缺乏更高 附加值的制剂产品出口。 公司胰岛素制剂"出海"陡然提速：二代胰岛素制剂先后拿下乌兹别克斯坦、尼加拉瓜两张"通行证"，三 代胰岛素制剂又相继在缅甸、印尼获批上市，一口气叩开四国大门。密集落地的海外批件，是近年来国 际注册工作持续深耕的集中兑现，也标志着国际化战略从"蓄力"迈入"收获"，阶段性战果正在快速放 大。 除了以上"一带一路"或新兴市场，通化东宝同样在重要的欧美市场持续推进，三季度公司门冬胰岛素的 美国 BLA（生物制品许可申请）获 FDA（美国食品药品监督管理局）受理；后续将推进甘精胰岛素、 赖脯胰岛素的美国 BLA 申报，并有序筹备欧洲市场注册资料与申请工作。 10 月 27 日晚间，国产胰岛素龙头通化东宝（以下简称"公司"）发布了 2025 年三季度报告，核心经营 数据与战略进展亮点突出。 报告显示，第三季度，通化东宝实现营业收入 8.06 亿元，同比增长 13.90%；归母净利润 9.84 亿元，同 比激增 499. ...

Summary of Key Points Core Viewpoint - A total of 853 companies released their Q3 2025 financial reports, with 475 reporting year-on-year profit growth and 378 reporting declines. Revenue growth was seen in 531 companies, while 322 experienced a decrease. Notably, 372 companies had both profit and revenue growth, while 219 saw declines in both metrics. There were 100 companies with profit growth exceeding 100%, with Fangzheng Electric showing the highest increase at 153,128.60% [1]. Group 1: Company Performance - Fangzheng Electric reported earnings per share of 0.0277, with a net profit of 13.76 million and a year-on-year increase of 153,128.60%. Revenue reached 201.25 million, up 10.44% [1]. - Tonghua Dongbao achieved earnings per share of 0.6100, net profit of 120.22 million, and a year-on-year increase of 1,911.35%. Revenue was 217.96 million, up 50.55% [1]. - ST Songfa reported earnings per share of 2.7400, net profit of 127.13 million, with a year-on-year increase of 1,614.08%. Revenue was 1,175.85 million, up 237.23% [1]. - Saiwei Electronics had earnings per share of 2.1521, net profit of 157.58 million, with a year-on-year increase of 1,438.05%. Revenue was 68.19 million, down 17.37% [1]. Group 2: Notable Companies with Declines - Liou Holdings reported earnings per share of 0.0870, net profit of 58.89 million, with a year-on-year increase of 469.10%. Revenue was 1,445.41 million, down 8.80% [2]. - TuoSida reported earnings per share of 0.1000, net profit of 4.93 million, with a year-on-year increase of 446.75%. Revenue was 168.77 million, down 24.49% [2]. - Zhongyida reported earnings per share of 0.0421, net profit of 4.51 million, with a year-on-year increase of 399.07%. Revenue was 76.16 million, down 6.07% [2]. - Jushi Holdings reported earnings per share of 0.0115, net profit of 1.11 million, with a year-on-year increase of 397.11%. Revenue was 174.33 million, up 13.20% [2].

Core Insights - As of October 28, 2023, 2,163 companies have released their Q3 2025 reports, with 1,248 reporting year-on-year profit growth and 915 reporting declines [1] - A total of 1,342 companies saw year-on-year revenue growth, while 821 experienced declines [1] - Companies with both profit and revenue growth include 963 firms, while 536 companies reported declines in both metrics [1] - Notably, 284 companies achieved a profit growth rate exceeding 100%, with Fangzheng Electric leading at a staggering 153,128.60% [1] Company Performance Summary - **Fangzheng Electric (002196)**: Earnings per share (EPS) of 0.0277, net profit of 13.76 million, net profit growth of 153,128.60%, and revenue of 201.25 million with a growth of 10.44% [1] - **Jingrui Technology (300655)**: EPS of 0.1212, net profit of 128.37 million, net profit growth of 19,202.65%, and revenue of 128.68 million with a growth of 11.92% [1] - **Tianbao Construction (000965)**: EPS of 0.0582, net profit of 64.61 million, net profit growth of 7,158.91%, and revenue of 232.00 million with a growth of 47.99% [1] - **Chengtian Weiye (300689)**: EPS of 0.1090, net profit of 12.42 million, net profit growth of 2,925.45%, and revenue of 31.01 million with a growth of 24.48% [1] - **Shenzhen Housing A (000029)**: EPS of 0.1434, net profit of 145.12 million, net profit growth of 2,791.57%, and revenue of 89.89 million with a growth of 331.66% [1] Additional Company Highlights - **Tonghua Dongbao (600867)**: EPS of 0.6100, net profit of 1,202.23 million, net profit growth of 1,911.35%, and revenue of 2,179.59 million with a growth of 50.55% [1] - **ST Songfa (603268)**: EPS of 2.7400, net profit of 1,271.35 million, net profit growth of 1,614.08%, and revenue of 11,758.50 million with a growth of 237.23% [1] - **Xingye Technology (300322)**: EPS of 0.1102, net profit of 50.71 million, net profit growth of 1,290.66%, and revenue of 198.98 million with a growth of 50.25% [2] - **Beisimei (300796)**: EPS of 0.0900, net profit of 31.17 million, net profit growth of 1,257.94%, and revenue of 111.03 million with a growth of 14.29% [2] - **Guanghua Technology (002741)**: EPS of 0.1944, net profit of 90.39 million, net profit growth of 1,233.70%, and revenue of 204.43 million with a growth of 11.50% [2]

MACD金叉信号形成，这些股涨势不错！ 公募基金方面，本期较上一期持股增加的公募基金共计1个，即创新药，持股增加占比小幅上涨。本期 较上一季度持股减少的公募基金共计2个，包括招商国证生物医药指数A、南方中证500ETF，持股减少 占比达0.17%。本期较上一季未再披露的公募基金共计249个，主要包括天弘国证生物医药ETF、国泰中 证生物医药ETF、广发创新药ETF、汇添富中证生物科技指数(LOF)A、银河医药混合A等。 2025年10月28日，通化东宝(600867.SH)发布2025年第三季报。截至2025年10月27日，共有9个机构投资 者披露持有通化东宝A股股份，合计持股量达9.28亿股，占通化东宝总股本的47.39%。其中，机构投资 者包括东宝实业集团股份有限公司、天津桢逸股权投资合伙企业(有限合伙)、香港中央结算有限公司、 阿布达比投资局、中国银行股份有限公司-招商国证生物医药指数分级证券投资基金、中国农业银行股 份有限公司-中证500交易型开放式指数证券投资基金、上海银行股份有限公司-银华中证创新药产业交 易型开放式指数证券投资基金、通化东宝药业股份有限公司-2025年员工持股计划、通化吉祥创赢投 ...

通化东宝（600867）10月27日发布2025年第三季度报告，前三季度，公司实现营业收入21.8亿元，同比 增长50.55%；实现净利润12.02亿元，上年同期为-6637万元。其中，第三季度，实现营业收入8.06亿 元，同比增长13.9%；净利润为9.84亿元，同比增长499.86%。 从通化东宝最新披露的2025年第三季度报告看，公司前三季度营业收入之所以同比增长50.55%，主要 系报告期胰岛素类似物产品销量增长显著，带动国内销售收入增长，同时报告期内海外业务多点突破， 带动出口收入增长所致。 通化东宝第三季度净利润同比增长499.86%，主要系报告期营业收入增长及转让特宝生物股票产生收益 所致。 回溯前情，通化东宝于2025年5月22日与西藏信托有限公司(代表"西藏信托-金桐35号集合资金信托计 划")签署了《股份转让协议》，以协议转让方式转让特宝生物(688278)无限售条件流通股股份2318.76万 股，占特宝生物总股本的5.70%，转让价格56.12元/股,转让价款总额为人民币13.01亿元。公司已于2025 年7月3日取得中国证券登记结算有限责任公司出具的《证券过户登记确认书》，过户日期为2 ...

Major Events - Guizhou Moutai's chairman Zhang Deqin resigned due to work adjustments, with Chen Hua recommended as the new chairman [4] - Kid King plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [5] - Postal Savings Bank received approval to establish a financial asset investment company with a registered capital of 10 billion RMB [6] - Seres announced that the maximum price for its H-share issuance will not exceed 131.5 HKD per share [7] - China Bank appointed Liu Chenggang as vice president [8] - ST Guangwu's stock will be delisted from risk warning and renamed to "Guanghui Logistics" [9] - Wireless Media's initial pricing for share transfer is set at 29.11 RMB per share [10] - Jiangshan Oupai's subsidiaries in Henan and Chongqing will cease operations due to insufficient orders and will transfer business to Zhejiang [11][12] - Zhenyu Technology plans to invest 2.11 billion RMB in precision component manufacturing and humanoid robot projects [13] - Jinyuan Co.'s general manager Lian Changyun resigned, with Qiu Yongping appointed as the new general manager [14] Performance Overview - CanSino reported a Q3 net profit of 27.93 million RMB, up 842.01% year-on-year [15] - Jiangshan Co. achieved a Q3 net profit of 86.73 million RMB, a significant increase of 11,890.01% year-on-year [16] - Yingshi Innovation's Q3 net profit decreased by 15.90% to 272 million RMB [17] - Chip Origin reported a Q3 net loss of 26.85 million RMB [18] - Tonghua Dongbao's Q3 net profit surged by 499.86% to 984 million RMB [19] - Hengrui Medicine's Q3 net profit increased by 9.53% to 1.301 billion RMB [20] - Zhongguang Lightning's Q3 net profit rose by 382.66% to 6.46 million RMB [21] - Ice River Network's Q3 net profit grew by 244.58% to 166 million RMB [22] - Daheng Technology's Q3 net profit skyrocketed by 1,960.72% to 71.48 million RMB [23] - Yanjin Puzhi's Q3 net profit increased by 33.55% to 232 million RMB [24] - Sichuan Gold's Q3 net profit reached 160 million RMB, up 184.38% year-on-year [26] - Sanbo Brain Science's Q3 net profit fell by 63.26% to 13.93 million RMB [27] - Hengli Petrochemical's Q3 net profit rose by 81.47% to 1.972 billion RMB [28] - Deepin Technology's Q3 net profit surged by 1,097.40% to 147 million RMB [29] - Huisheng Biological's Q3 net profit increased by 1,575.79% to 70.72 million RMB [30] - Gaode Infrared's Q3 net profit grew by 1,143.72% to 401 million RMB [31] - Qingdao Beer reported a Q3 net profit of 1.37 billion RMB, up 1.62% [32] - Nanjing Public Utilities' Q3 net profit soared by 2,492.12% to 84.62 million RMB [34] - Zhangyuan Tungsten's Q3 net profit increased by 118.56% to 75.02 million RMB [35] - Yongmaotai's Q3 net profit rose by 6,319.92% to 30.41 million RMB [36] - Northern Rare Earth's Q3 net profit increased by 69.48% to 610 million RMB [37] - Hunan Gold's Q3 net profit grew by 63.13% to 373 million RMB [38] - Wansheng Intelligent's Q3 net profit increased by 205.56% to 67.13 million RMB [39] - Saiwei Electronics reported a Q3 net profit of 1.576 billion RMB, up 2,199.10% [40] Financing Activities - Lingzhi Software is planning to acquire control of Kaimiride and raise matching funds [41] Major Contracts - High-speed Rail Electric has pre-qualified for a 62.39 million RMB urban rail transit project [42]

转自：贝壳财经 编辑 王进雨 新京报贝壳财经讯 10月27日，通化东宝发布2025年第三季度报告，前三季度实现营业收入21.80亿元， 同比增长50.55%；归属于上市公司股东的净利润12.02亿元。第三季度实现营业收入8.06亿元，同比增 长13.90%；归属于上市公司股东的净利润9.84亿元，同比增长499.86%。 ...

Core Viewpoint - Tonghua Dongbao (600867.SH) reported a significant turnaround in its financial performance for the first three quarters of 2025, showcasing strong revenue growth and a return to profitability [1] Financial Performance - The company achieved total operating revenue of 2.18 billion yuan, representing a year-on-year increase of 50.55% [1] - The net profit attributable to shareholders was 1.202 billion yuan, compared to a loss of 66.3724 million yuan in the same period last year [1] - Basic earnings per share were reported at 0.61 yuan [1]

Group 1 - Northern Rare Earth reported a net profit increase of 280% year-on-year for the first three quarters, driven by higher sales volume and prices of rare earth products [1] - Postal Savings Bank has received approval to establish a financial asset investment company with a registered capital of 10 billion yuan, aimed at enhancing comprehensive service capabilities and supporting technological innovation [2] - Silyus announced a maximum price of HKD 131.5 per share for its H-share issuance, with a total of 100.2 million shares available for global offering [3] Group 2 - Hengtong Optic-Electric won a bid for marine energy projects with a total contract value of 1.868 billion yuan, including the supply and construction of undersea cables [4] - Western Mining's subsidiary Yulong Copper won exploration rights for the Chating copper polymetallic mine for 8.609 billion yuan, which is expected to enhance the company's resource reserves [5] - China Bank appointed Liu Chenggang as vice president, effective from October 24, 2025 [6] Group 3 - ST Guangwu announced the removal of other risk warnings for its stock, changing its name to Guanghui Logistics, which will allow for a wider trading limit [7] - Wireless Media set an initial transfer price of 29.11 yuan per share for its inquiry transfer, with a subscription multiple of 2.01 times [8][9] - Jiangshan Oupai's subsidiaries in Henan and Chongqing will cease operations due to insufficient orders, with business transferred to its Zhejiang base [10] Group 4 - Zhenyu Technology plans to invest 2.11 billion yuan in precision component manufacturing and humanoid robot projects, with the first phase of investment to be signed soon [11] - Jinyuan Co. announced the resignation of its general manager, with Qiu Yongping appointed as the new general manager [12] Group 5 - CanSino reported a net profit of 27.93 million yuan for Q3, a year-on-year increase of 842.01% [13] - Jiangshan Co. reported a net profit of 86.73 million yuan for Q3, a year-on-year increase of 11,890.01% [14] - Yingshi Innovation reported a net profit of 272 million yuan for Q3, a year-on-year decrease of 15.90% [15] Group 6 - Chip Origin reported a net loss of 26.85 million yuan for Q3, despite a revenue increase of 78.38% [16] - Tonghua Dongbao reported a net profit of 984 million yuan for Q3, a year-on-year increase of 499.86% [17] - Hengrui Medicine reported a net profit of 1.301 billion yuan for Q3, a year-on-year increase of 9.53% [18] Group 7 - Zhongguang Lightning reported a net profit of 6.46 million yuan for Q3, a year-on-year increase of 382.66% [19] - Ice River Network reported a net profit of 166 million yuan for Q3, a year-on-year increase of 244.58% [20] - Daheng Technology reported a net profit of 71.48 million yuan for Q3, a year-on-year increase of 1,960.72% [21] Group 8 - Yanjin Puzhi reported a net profit of 232 million yuan for Q3, a year-on-year increase of 33.55% [22] - Sichuan Gold reported a net profit of 160 million yuan for Q3, a year-on-year increase of 184.38% [23] - Sanbo Brain Science reported a net profit of 13.93 million yuan for Q3, a year-on-year decrease of 63.26% [24] Group 9 - Hengli Petrochemical reported a net profit of 1.972 billion yuan for Q3, a year-on-year increase of 81.47% [25] - Deepin Technology reported a net profit of 147 million yuan for Q3, a year-on-year increase of 1,097.40% [26] - Huisheng Biological reported a net profit of 70.72 million yuan for Q3, a year-on-year increase of 1,575.79% [27] Group 10 - Gaode Infrared reported a net profit of 401 million yuan for Q3, a year-on-year increase of 1,143.72% [28] - Qingdao Beer reported a net profit of 1.37 billion yuan for Q3, a year-on-year increase of 1.62% [29] - Nanjing Public Utilities reported a net profit of 84.62 million yuan for Q3, a year-on-year increase of 2,492.12% [30] Group 11 - Zhangyuan Tungsten reported a net profit of 75.02 million yuan for Q3, a year-on-year increase of 118.56% [31] - Yongmaotai reported a net profit of 30.41 million yuan for Q3, a year-on-year increase of 6,319.92% [32] Group 12 - Tongrun Equipment announced that two shareholders plan to reduce their holdings by 1.50% each, totaling a maximum of 3.00% [33] - High-speed Rail Electric announced a pre-bid for a city rail transit project worth 62.39 million yuan [34]

Core Viewpoint - Tonghua Dongbao (600867) reported significant growth in revenue and net profit for the first three quarters of 2025, indicating a strong financial performance driven by increased sales and investment gains [1] Financial Performance - The company achieved an operating revenue of 2.18 billion yuan, representing a year-on-year increase of 50.55% [1] - The net profit attributable to shareholders reached 1.202 billion yuan, marking a turnaround from losses in the previous year [1] Factors Influencing Growth - The increase in net profit is primarily attributed to the growth in operating revenue and gains from the transfer of shares in Te Bao Biological [1]